Literature DB >> 16398675

Characterization of biliary intra-epithelial lymphocytes at different anatomical levels of intrahepatic bile ducts under normal and pathological conditions: numbers of CD4+CD28- intra-epithelial lymphocytes are increased in primary biliary cirrhosis.

Kumiko Isse1, Kenichi Harada, Yasunori Sato, Yasuni Nakanuma.   

Abstract

Distribution of intra-epithelial lymphocytes along intrahepatic biliary tree (bIEL), and their density and phenotype were examined in normal and diseased livers, particularly in primary biliary cirrhosis (PBC). Immunohistochemically, bIEL were examined in 28 normal livers, 13 cases of chronic viral hepatitis (CVH), 13 cases of PBC, five cases of primary sclerosing cholangitis (PSC), seven cases of extrahepatic biliary obstruction (EBO), and 16 hepatolithiatic livers. In normal livers, bIEL were relatively dense at large and septal bile ducts compared to interlobular ducts. Most of them were positive for CD3 and CD8, while a few were positive for CD4, CD20 and CD57. In CVH, PSC and EBO, neither distribution, phenotype nor density of bIEL differed from normal liver. In hepatolithiasis, numbers of CD8(+)bIEL were increased in stone-containing ducts. In PBC, numbers of CD4(+)CD28(-)bIEL, which are reportedly responsible for target tissue destruction in autoimmune diseases, were markedly increased in damaged interlobular ducts. In conclusion, CD3(+)CD8(+)bIEL may be involved in immune homeostasis of intrahepatic bile ducts in normal livers and in CVH, PSC and EBO. Altered distribution and phenotypes of bIEL in PBC and hepatolithiasis may reflect their participation in biliary lesions. Increased CD4(+)CD28(-)bIEL in damaged bile ducts of PBC may be related to immune-mediated biliary damage.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16398675     DOI: 10.1111/j.1440-1827.2006.01913.x

Source DB:  PubMed          Journal:  Pathol Int        ISSN: 1320-5463            Impact factor:   2.534


  10 in total

1.  Etiopathogenesis of primary biliary cirrhosis: an overview of recent developments.

Authors:  Palak J Trivedi; Sue Cullen
Journal:  Hepatol Int       Date:  2012-03-20       Impact factor: 6.047

Review 2.  Primary biliary cirrhosis: what we know and what we want to know about human PBC and spontaneous PBC mouse models.

Authors:  Yoshiyuki Ueno; Yuki Moritoki; Tooru Shimosegawa; M Eric Gershwin
Journal:  J Gastroenterol       Date:  2007-03-30       Impact factor: 7.527

3.  Immunohistochemical study of the local immune response in lambs experimentally infected with Dicrocoelium dendriticum (Digenea).

Authors:  M Carmen Ferreras-Estrada; R Campo; C González-Lanza; V Pérez; J F García-Marín; M Y Manga-González
Journal:  Parasitol Res       Date:  2007-03-29       Impact factor: 2.289

Review 4.  Liver architecture, cell function, and disease.

Authors:  Hiromi Ishibashi; Minoru Nakamura; Atsumasa Komori; Kiyoshi Migita; Shinji Shimoda
Journal:  Semin Immunopathol       Date:  2009-05-26       Impact factor: 9.623

5.  Tutorial review for understanding of cholangiopathy.

Authors:  Yasuni Nakanuma
Journal:  Int J Hepatol       Date:  2011-08-17

Review 6.  Molecular mechanisms of cholangiopathy in primary biliary cirrhosis.

Authors:  Kenichi Harada; Yasuni Nakanuma
Journal:  Med Mol Morphol       Date:  2006-06       Impact factor: 2.070

Review 7.  Cholangiocarcinoma with respect to IgG4 Reaction.

Authors:  Kenichi Harada; Yasuni Nakanuma
Journal:  Int J Hepatol       Date:  2014-07-15

Review 8.  Lymphopenia, Lymphopenia-Induced Proliferation, and Autoimmunity.

Authors:  Ting-Ting Sheu; Bor-Luen Chiang
Journal:  Int J Mol Sci       Date:  2021-04-16       Impact factor: 5.923

Review 9.  Lymphocyte recruitment and homing to the liver in primary biliary cirrhosis and primary sclerosing cholangitis.

Authors:  Andrea T Borchers; Shinji Shimoda; Christopher Bowlus; Carl L Keen; M Eric Gershwin
Journal:  Semin Immunopathol       Date:  2009-06-17       Impact factor: 9.623

10.  Loss of CD28 expression by liver-infiltrating T cells contributes to pathogenesis of primary sclerosing cholangitis.

Authors:  Evaggelia Liaskou; Louisa E Jeffery; Palak J Trivedi; Gary M Reynolds; Shankar Suresh; Tony Bruns; David H Adams; David M Sansom; Gideon M Hirschfield
Journal:  Gastroenterology       Date:  2014-04-12       Impact factor: 22.682

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.